Full Year 2018 Indivior PLC Earnings Call Transcript
Okay. Good morning, everybody, and welcome to the full year results for 2018 for Indivior. My name is Shaun Thaxter. I am the Chief Executive Officer, and I'm looking forward today with my colleagues, Mark Crossley, Chief Financial Officer; Javier Rodriguez, Chief Legal Officer; and Christian Heidbreder, Chief Scientific Officer to sharing with you the results from last year, our plans for this year as we continue to pursue our journey towards our vision to ensure that patients all around the world have unrestricted access to evidence-based treatments for the chronic relapsing conditions and the co- occurring disorders of addiction.
I will assume that you've read the forward-looking statements. And our agenda today is I will give an overview, then Mark will give a financial report, we'll have a legal update, and then we'll look at some new exciting scientific data on progress that's been made in our R&D and medical functions last year.
Well, clearly, 2018 was a challenging year with net revenues dropping from the prior year.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |